IBDEI11K ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18558,0)
 ;;=90885^^102^1067^19^^^^1
 ;;^UTILITY(U,$J,358.3,18558,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18558,1,2,0)
 ;;=2^90885
 ;;^UTILITY(U,$J,358.3,18558,1,3,0)
 ;;=3^Psych Eval of Records
 ;;^UTILITY(U,$J,358.3,18559,0)
 ;;=90889^^102^1067^17^^^^1
 ;;^UTILITY(U,$J,358.3,18559,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18559,1,2,0)
 ;;=2^90889
 ;;^UTILITY(U,$J,358.3,18559,1,3,0)
 ;;=3^Preparation of Report
 ;;^UTILITY(U,$J,358.3,18560,0)
 ;;=96118^^102^1067^15^^^^1
 ;;^UTILITY(U,$J,358.3,18560,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18560,1,2,0)
 ;;=2^96118
 ;;^UTILITY(U,$J,358.3,18560,1,3,0)
 ;;=3^Neuropsych Tst/Hr of Psychologist/MD Time
 ;;^UTILITY(U,$J,358.3,18561,0)
 ;;=97530^^102^1067^30^^^^1
 ;;^UTILITY(U,$J,358.3,18561,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18561,1,2,0)
 ;;=2^97530
 ;;^UTILITY(U,$J,358.3,18561,1,3,0)
 ;;=3^Therapeutic Activ,Dir Prov Contact,ea 15min
 ;;^UTILITY(U,$J,358.3,18562,0)
 ;;=G0177^^102^1067^31^^^^1
 ;;^UTILITY(U,$J,358.3,18562,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18562,1,2,0)
 ;;=2^G0177
 ;;^UTILITY(U,$J,358.3,18562,1,3,0)
 ;;=3^Train/Ed for Disability > 44 Min
 ;;^UTILITY(U,$J,358.3,18563,0)
 ;;=H0038^^102^1067^25^^^^1
 ;;^UTILITY(U,$J,358.3,18563,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18563,1,2,0)
 ;;=2^H0038
 ;;^UTILITY(U,$J,358.3,18563,1,3,0)
 ;;=3^Self-Help/Peer Svc per 15 Min
 ;;^UTILITY(U,$J,358.3,18564,0)
 ;;=J1630^^102^1067^8^^^^1
 ;;^UTILITY(U,$J,358.3,18564,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18564,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,18564,1,3,0)
 ;;=3^Haloperidol,Up to 5mg
 ;;^UTILITY(U,$J,358.3,18565,0)
 ;;=J2794^^102^1067^24^^^^1
 ;;^UTILITY(U,$J,358.3,18565,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18565,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,18565,1,3,0)
 ;;=3^Risperidone,Long Acting per 0.5mg
 ;;^UTILITY(U,$J,358.3,18566,0)
 ;;=97150^^102^1067^6^^^^1
 ;;^UTILITY(U,$J,358.3,18566,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18566,1,2,0)
 ;;=2^97150
 ;;^UTILITY(U,$J,358.3,18566,1,3,0)
 ;;=3^Group Therapeutic Procedures
 ;;^UTILITY(U,$J,358.3,18567,0)
 ;;=1160F^^102^1067^11^^^^1
 ;;^UTILITY(U,$J,358.3,18567,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18567,1,2,0)
 ;;=2^1160F
 ;;^UTILITY(U,$J,358.3,18567,1,3,0)
 ;;=3^Medication Review by Provider
 ;;^UTILITY(U,$J,358.3,18568,0)
 ;;=2010F^^102^1067^32^^^^1
 ;;^UTILITY(U,$J,358.3,18568,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18568,1,2,0)
 ;;=2^2010F
 ;;^UTILITY(U,$J,358.3,18568,1,3,0)
 ;;=3^Vital Signs
 ;;^UTILITY(U,$J,358.3,18569,0)
 ;;=99090^^102^1067^23^^^^1
 ;;^UTILITY(U,$J,358.3,18569,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18569,1,2,0)
 ;;=2^99090
 ;;^UTILITY(U,$J,358.3,18569,1,3,0)
 ;;=3^Record Review (Labs,Remote Data)
 ;;^UTILITY(U,$J,358.3,18570,0)
 ;;=96101^^102^1067^22^^^^1
 ;;^UTILITY(U,$J,358.3,18570,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18570,1,2,0)
 ;;=2^96101
 ;;^UTILITY(U,$J,358.3,18570,1,3,0)
 ;;=3^Psych Testing by Psych/Phys per hr
 ;;^UTILITY(U,$J,358.3,18571,0)
 ;;=96127^^102^1067^2^^^^1
 ;;^UTILITY(U,$J,358.3,18571,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18571,1,2,0)
 ;;=2^96127
 ;;^UTILITY(U,$J,358.3,18571,1,3,0)
 ;;=3^Brf Emot/Behav Assmt w/ Score/Doc
 ;;^UTILITY(U,$J,358.3,18572,0)
 ;;=96150^^102^1068^1^^^^1
 ;;^UTILITY(U,$J,358.3,18572,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18572,1,2,0)
 ;;=2^96150
 ;;^UTILITY(U,$J,358.3,18572,1,3,0)
 ;;=3^Behavior Assess,Initial,ea 15min
 ;;^UTILITY(U,$J,358.3,18573,0)
 ;;=96151^^102^1068^2^^^^1
 ;;^UTILITY(U,$J,358.3,18573,1,0)
 ;;=^358.31IA^3^2
